Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,842 | 445 | 99.6% |
| Education | $24.22 | 7 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $953.80 | 66 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $784.36 | 45 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $668.43 | 33 | $0 (2024) |
| Daiichi Sankyo Inc. | $597.45 | 51 | $0 (2019) |
| Lundbeck LLC | $471.13 | 27 | $0 (2024) |
| Boston Scientific Corporation | $454.26 | 24 | $0 (2024) |
| Assertio Therapeutics, Inc. | $341.84 | 37 | $0 (2020) |
| RedHill Biopharma Inc. | $274.28 | 16 | $0 (2022) |
| Scilex Pharmaceuticals Inc. | $217.10 | 13 | $0 (2022) |
| Amgen Inc. | $210.71 | 12 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $336.10 | 18 | Collegium Pharmaceutical, Inc. ($90.16) |
| 2023 | $649.67 | 35 | Collegium Pharmaceutical, Inc. ($190.91) |
| 2022 | $866.13 | 43 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($224.62) |
| 2021 | $984.81 | 61 | RedHill Biopharma Inc. ($164.85) |
| 2020 | $445.96 | 26 | Collegium Pharmaceutical, Inc. ($103.47) |
| 2019 | $1,129 | 77 | ASSERTIO THERAPEUTICS, Inc. ($184.44) |
| 2018 | $1,490 | 110 | Daiichi Sankyo Inc. ($364.48) |
| 2017 | $964.12 | 82 | PFIZER INC. ($303.38) |
All Payment Transactions
452 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: PAIN | ||||||
| 09/30/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $17.10 | General |
| Category: Opioid Analgesic | ||||||
| 07/03/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Neuromodulation | ||||||
| 07/02/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.08 | General |
| Category: NEUROLOGY | ||||||
| 06/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 06/11/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $16.42 | General |
| Category: Opioid Analgesic | ||||||
| 05/21/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $18.12 | General |
| Category: Opioid Analgesic | ||||||
| 04/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: PAIN | ||||||
| 04/10/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $17.04 | General |
| Category: NEUROLOGY | ||||||
| 03/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Gastroenterology | ||||||
| 03/26/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $18.12 | General |
| Category: Opioid Analgesic | ||||||
| 03/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $14.95 | General |
| Category: NEUROLOGY | ||||||
| 02/06/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.38 | General |
| Category: NEUROLOGY | ||||||
| 01/18/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $20.40 | General |
| Category: Opioid Analgesic | ||||||
| 01/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2023 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $13.38 | General |
| Category: NEUROLOGY | ||||||
| 11/27/2023 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $16.91 | General |
| Category: Opioid Analgesic | ||||||
| 11/01/2023 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $19.07 | General |
| Category: NEUROLOGY | ||||||
| 10/26/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: PAIN | ||||||
| 10/04/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Gastroenterology | ||||||
| 09/18/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $21.75 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 281 | 890 | $213,340 | $57,081 |
| 2022 | 3 | 314 | 982 | $233,795 | $63,983 |
| 2021 | 3 | 340 | 1,062 | $180,550 | $70,802 |
| 2020 | 3 | 382 | 1,229 | $201,980 | $65,205 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 111 | 436 | $135,160 | $36,279 | 26.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 89 | 350 | $73,500 | $19,517 | 26.6% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 81 | 104 | $4,680 | $1,284 | 27.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 117 | 485 | $150,350 | $41,338 | 27.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 95 | 372 | $77,910 | $21,140 | 27.1% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 102 | 125 | $5,535 | $1,504 | 27.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 133 | 471 | $101,265 | $41,648 | 41.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 112 | 479 | $74,245 | $27,764 | 37.4% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2021 | 95 | 112 | $5,040 | $1,390 | 27.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 134 | 465 | $99,975 | $32,974 | 33.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 136 | 616 | $95,480 | $30,427 | 31.9% |
| 80305 | Testing for presence of drug | Office | 2020 | 112 | 148 | $6,525 | $1,804 | 27.6% |
About Dr. Mark Phillips, MD
Dr. Mark Phillips, MD is a Pain Medicine healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275511966.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Phillips, MD has received a total of $6,866 in payments from pharmaceutical and medical device companies, with $336.10 received in 2024. These payments were reported across 452 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($6,842).
As a Medicare-enrolled provider, Phillips has provided services to 1,317 Medicare beneficiaries, totaling 4,163 services with total Medicare billing of $257,070. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Location Greensboro, NC
- Active Since 01/04/2006
- Last Updated 03/30/2009
- Taxonomy Code 208VP0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1275511966
Products in Payments
- RELISTOR (Drug) $618.58
- LYRICA (Drug) $576.00
- XTAMPZA (Drug) $539.17
- VYEPTI (Biological) $471.13
- Movantik (Drug) $467.72
- Morphabond ER (Drug) $394.29
- Belbuca (Drug) $212.02
- SPECTRA WAVEWRITER (Device) $207.99
- Nucynta (Drug) $172.86
- Aimovig (Biological) $166.07
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $139.27
- Gralise (Drug) $136.69
- Cambia (Drug) $130.56
- BELBUCA (Drug) $125.84
- NURTEC ODT (Drug) $124.70
- RELISTOR ORAL (Drug) $107.83
- Licart (Drug) $104.07
- Amitiza (Drug) $86.89
- Senza Spinal Cord Stimulation System (Device) $76.37
- HYSINGLA ER (Drug) $68.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Greensboro
Amanda Lawson, Np, NP
Pain Medicine — Payments: $2,681
Darren Bates, Pa-C, PA-C
Pain Medicine — Payments: $1,702
Barbara Goldman, Pa-C, PA-C
Pain Medicine — Payments: $793.90
Dr. Farooque Khan, Md, MD
Pain Medicine — Payments: $508.71
Shraddha Khokhal
Pain Medicine — Payments: $363.45
Dr. Mitchell Bloom, M.d, M.D
Pain Medicine — Payments: $109.75